-
461
Cross-Session Emotion Recognition by Joint Label-Common and Label-Specific EEG Features Exploration
Published 2023-01-01Get full text
Article -
462
Optimized Refactoring Mechanisms to Improve Quality Characteristics in Object-Oriented Systems
Published 2023-01-01Get full text
Article -
463
Long-Term Ultraviolet Treatment for Macrofouling Control in Northern and Southern Hemispheres
Published 2023-11-01Get full text
Article -
464
-
465
Federated Deep Learning for Monkeypox Disease Detection on GAN-Augmented Dataset
Published 2024-01-01Get full text
Article -
466
-
467
-
468
-
469
-
470
An Adaptive Wake-Up-Interval to Enhance Receiver-Based Ps-Mac Protocol for Wireless Sensor Networks
Published 2019-08-01Get full text
Article -
471
Early Real-World Treatment Patterns and Clinical Outcomes in Patients with Metastatic Breast Cancer Treated with Eribulin After Prior Immuno-Oncology or Antibody–Drug Conjuga...
Published 2023-11-01“…Ravi K Goyal,1 Jingchuan Zhang,2 Keith L Davis,1 Martina Sluga-O’Callaghan,1 Peter A Kaufman3 1Health Economics, RTI Health Solutions, Research Triangle Park, NC, USA; 2Eisai Inc., Nutley, NJ, USA; 3Larner College of Medicine, Division of Hematology/Oncology, University of Vermont Cancer Center, Burlington, VT, USACorrespondence: Peter A Kaufman, Larner College of Medicine, Division of Hematology/Oncology, University of Vermont Cancer Center, 111 Colchester Avenue, EP2, Burlington, VT, 05401, USA, Email Peter.Kaufman@uvmhealth.orgIntroduction: Eribulin was approved by the FDA in 2010 for the treatment of metastatic breast cancer (MBC) in the United States (US). …”
Get full text
Article -
472
-
473
-
474
Trust Management in Social Internet of Things (SIoT): A Survey
Published 2022-01-01Get full text
Article -
475
Smart-Object-Based Reasoning System for Indoor Acoustic Profiling of Elderly Inhabitants
Published 2021-06-01Get full text
Article -
476
-
477
-
478
-
479
-
480